Amongst Women Stratified to Receive Endocrine Therapy on the Basis of Their Tumor Estrogen and Progesterone Receptor Levels, Those with Higher Tumor Progesterone Receptor Levels Had a Better Outcome Than Those with Lower Levels of Tumor Progesterone Receptor

Tai‐Han Lin(Tri-Service General Hospital), Cheng‐Ping Yu(Tri-Service General Hospital), Guo‐Shiou Liao(Tri-Service General Hospital), Ming‐Shen Dai(Tri-Service General Hospital), Jyh‐Cherng Yu(Tri-Service General Hospital), Hong‐Wei Gao(Tri-Service General Hospital), Jar‐Yi Ho(Tri-Service General Hospital)
Cancers
February 21, 2021
Cited by 6


Related Papers